LINC01792: A Drug Target / Disease Biomarker (G100507140)

Target Name: LINC01792

NCBI ID: G100507140

LINC01792

Other Name(s): long intergenic non-protein coding RNA 1792 | Long intergenic non-protein coding RNA 1792

LINC01792: A Drug Target / Disease Biomarker

LINC01792 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, and recent studies have shed new light on its potential as a therapeutic agent.

LINC01792 is a long non-coding RNA molecule that is approximately 200 amino acids long. It is expressed in various tissues and cells throughout the body and is involved in the regulation of gene expression. Its function is not well understood, but it is believed to play a role in the development and progression of certain diseases.

One of the key features of LINC01792 is its ability to interact with protein molecules. This interaction is known as post-transcriptional modification (PTM), and it can alter the stability and function of the RNA molecule. LINC01792 has been shown to interact with several proteins, including the protein encoded by the gene SLC30F2.

SLC30F2 is a zinc transmembrane protein that is involved in a variety of cellular processes, including cell signaling, DNA replication, and metabolism. It is also a potential drug target for various diseases, including cancer. Researchers have shown that LINC01792 can interact with SLC30F2 and that this interaction may play a role in the regulation of gene expression.

Another study has shown that LINC01792 can interact with the protein encoded by the gene NLRP1. NLRP1 is a protein that is involved in the regulation of stress responses, including inflammation and DNA damage. It is also a potential drug target for various diseases, including cancer. Researchers have shown that LINC01792 can interact with NLRP1 and that this interaction may play a role in the regulation of gene expression.

In addition to its interaction with protein molecules, LINC01792 has also been shown to interact with the protein encoded by the gene TAS1F2. TAS1F2 is a protein that is involved in the regulation of cell signaling, including cell growth and differentiation. It is also a potential drug target for various diseases, including cancer. Researchers have shown that LINC01792 can interact with TAS1F2 and that this interaction may play a role in the regulation of gene expression.

Overall, LINC01792 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and function have made it an attractive target for researchers to study, and recent studies have shed new light on its potential as a therapeutic agent. Further research is needed to fully understand the role of LINC01792 in disease progression and the development of new therapeutic approaches.

Protein Name: Long Intergenic Non-protein Coding RNA 1792

The "LINC01792 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01792 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets